Skip to main content
See every side of every news story
Published • loading... • Updated

GSK Shares Slump as Vaccine Sales Decline Despite Revenue Beat

GSK says it remains 'focused on operational delivery, execution and accelerating R&D'

7 Articles

Evening StandardEvening Standard
+2 Reposted by 2 other sources
Center

GSK sees falling vaccine sales take shine off earnings

The drugs giant revealed vaccine sales fell 2% to £2.6 billion in the three months to September 30 as demand waned for its shingles and RSV jabs.

·London, United Kingdom
Read Full Article
Center

GSK shares fell to their lowest level in six months following the drugmaker's third-quarter earnings report, as a decline in vaccine sales raised concerns about growth prospects, Bloomberg reports.

·Budapest, Hungary
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources are Center
50% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

business-live.co.uk broke the news in London, United Kingdom on Wednesday, October 28, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal